View Press Releases
-
Takara Bio Europe unveils new large-scale NGS profiling system and chemistries
Takara Bio Europe has announced the launch of the Shasta™ Single-Cell System, a high-throughput NGS solution enabling novel biomarker discovery in oncology research, at the 2024 Human Cell Atlas General Meeting. This comprehensive system combines well-validated chemistries with user-friendly bioinformatics tools, allowing researchers to mine more genomic and transcriptomic information from a much greater number of cells than previously possible, all while reducing both time and costs. The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit increases throughput by processing up to 1,500 cells per run, compared to current technologies which are limited to 384 single cells, while also enabling the detection of single-cell level CNV events via shallow sequencing. Its ability to detect RNA biotypes, such as non-polyadenylated lncRNAs, otherwise missed by current droplet-based technologies represents a significant advancement over traditional plate-based full-length RNA-seq and high-throughput mRNA-seq methods.
Sep 25, 2024
-
Phastar Announced as 2024 Scrip Award Finalist for Best Contract Research Organization – Specialist Provider
Phastar’s Data Analytics and Visualization Portal and commitment to high ESG standards secures shortlist spot at the 20th Anniversary Scrip Awards
Sep 23, 2024
-
Duke Street Bio Granted Approval by European Medicines Agency to Launch Next-Generation PARP1-Selective Inhibitor Trial
Duke Street Bio Ltd has announced that the European Medicines Agency (EMA) has granted approval to commence a clinical trial for its highly-selective PARP1 inhibitor, DSB2455.
Sep 23, 2024
-
Endor Labs Brings Aboard Cybersecurity Veteran Karl Mattson as Chief Information Security Officer
Endor Labs, the leader in open source software security, today announced that industry veteran Karl Mattson has been named as the company’s first Chief Information Security Officer (CISO).
Sep 23, 2024
-
TOSS Machine Components Highlights PIREG®-545 Panel Mounted Impulse Heat Seal Controller for Biotechnology and Pharmaceutical Applications
The PIREG-545 impulse heat seal controller offers significant advantages in the medical and pharmaceutical markets. Its quick and precise control offers repeatable and consistent heat seal results critical for processes in need of validation as many life science applications demand. The PIREG-545 enhances quality control and compliance to industry standards.
Sep 23, 2024
-
Integrated DNA Technologies Unveils New Lymphoma Panel to Enhance Blood Cancer Research
-
Watson-Marlow Fluid Technology Solutions showcases recently launched WMArchitect™ single-use solutions along with a range of pumps and hoses at CPHI Milan 2024
Watson-Marlow Fluid Technology Solutions (WMFTS) will display a range of peristaltic pumps and associated fluid path technologies for the life sciences industry during CPHI Milan 2024 at Fiera Milano on 8th – 10th October.
Sep 18, 2024
-
MATTER Selected to Lead the Digital Health Hub in the Next Generation of the BARDA Accelerator Network
The Biomedical Advanced Research and Development Authority (BARDA) has selected MATTER to lead the new Digital Health Hub as part of the BARDA Accelerator Network. The hub, called Paratus, will support the development of next-gen digital health technologies to address health security threats.
Sep 16, 2024
-
Zymo Research Stands by Its Innovative cfDNA Technology in Response to Qiagen’s Lawsuit
Zymo Research Corporation, a leader in innovative life science solutions, acknowledges the patent infringement lawsuit filed by Qiagen GmbH on August 20, 2024, at the US District Court for the Central District of California regarding its MAGicBead cfDNA isolation technology. Zymo Research respects intellectual property rights and is confident that this technology represents a significant advancement in nucleic acid purification.
Sep 17, 2024
-
CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence
Phreesia, the National Association For Continence (NAFC), Health.Equity.Outcomes. and Christina Escobar, MD, at New York University, are proud to announce that the U.S. Centers for Disease Control and Prevention (CDC) has awarded a grant for a joint project focused on combating the public health challenge of urinary incontinence in women.
Sep 17, 2024
-
Sapio Sciences Partner Program Welcomes Astrix
Sapio Sciences, the science-aware™ lab informatics platform, today announced that Astrix, the market leader in creating and delivering innovative strategies, solutions, and people to the life science community, has joined the Sapio Sciences Partner Program, providing consulting and implementation services to life science and biotech customers.
Sep 16, 2024
-
eClinical Solutions Announces Growth Investment by GI Partners to Further Its Mission of Helping Bring Treatments to Patients Faster
eClinical Solutions LLC, a global provider of digital clinical software and services, today announced that GI Partners, a private investment firm, has made a majority investment in the company to advance the future of digital trials via continued enhancements to its leading AI-powered data products and biometrics services.
Sep 11, 2024
-
Global Cyber Security Expert, NCC Group Expands Digital Identity Services Amidst Growing Customer Demand
NCC Group has launched a new suite of digital identity services to help organizations manage and safeguard access to their digital assets, while optimizing operations and enhancing security.
Sep 12, 2024
-
Sunrise Labs, Inc. Selected as a Member of ARPA-H Investor Catalyst Hub Spoke Network
-
Cellares and Sony Announce a Joint Development Collaboration to Integrate Flow Cytometry-Based Sorting and Online Analysis into an Automated, High-Throughput Cell Therapy Manufacturing Platform
Cellares and Sony have announced a collaboration to integrate Sony’s flow cytometry-based sorting technology into Cellares' automated Cell Shuttle platform for cell therapy manufacturing. This integration will enhance automation, scalability, and real-time monitoring, improving the efficiency of sorting-dependent therapies like Treg and HSC. It aims to streamline the manufacturing process and reduce costs.
Sep 11, 2024
-
Opentrons introduces Flex Prep: A no-code robot offering the simplicity of a pipette with the versatility of a liquid handler
Opentrons introduces Flex Prep, a no-code robot combining the simplicity of a pipette with the versatility of a liquid handler. Its intuitive touchscreen allows scientists to program pipetting tasks in under a minute. Flex Prep enhances lab automation, offering affordable and versatile capabilities for both basic and complex protocols, empowering researchers to automate tasks without prior robotics experience.
Sep 11, 2024
-
GenNext and Agilent Unveil Groundbreaking Technology Integration to Accelerate High-Value Decision Making in Biopharmaceutical Research
GenNext Technologies has announced a pioneering collaboration with Agilent, that promises to transform structural biology research for biopharmaceutical companies.
Sep 10, 2024
-
Breakthrough towards protein sequencing using Oxford Nanopore holds promise for disease research and drug development
In a research collaboration with Oxford Nanopore Technologies, scientists from the University of Washington have unveiled a groundbreaking ‘proof-of-concept’ method for reading single protein molecules
Sep 10, 2024
-
Cleveland Diagnostics’ Prostate Cancer Awareness Campaign ‘A PSA on PSA’ Returns This September
National Initiative to Increase Education & Awareness; Raise Funds for ZERO Prostate Cancer with Donation Made for Every Patient Discussion Guide Downloaded at PSAonPSA.com
Sep 10, 2024
-
PathAI Launches MET Predict on AISight to Enhance NSCLC Assessments
PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced the launch of MET Predict† on the AISightⓇ† Image management system (IMS). MET Predict is an AI-powered algorithm designed to help pathologists identify non-small cell lung cancer (NSCLC) tumors that may be more likely to have MET exon 14 skipping (METex14) or MET amplification, directly from an H&E whole slide image.
Sep 9, 2024